Back

Rate, determinants and clinical impact of percutaneous closure success of patent foramen ovale-related hypoxemia

30 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Patent foramen ovale closure Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Gora Ndiaye

Civil Hospital/ Nouvel Hopital Civil, Strasbourg (France)

7 More presentations in this session

Presentation thumbnail
A predictive score for supraventricular arrythmia after Patent Foramen Ovale percutaneous Closure
Professor J. Silvain (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Comparison of Amplatzer and Gore Cardioform occluder for patent foramen ovale closure in patients with nickel hypersensitivity
Doctor A. Apostolos (London, GB)
Abstract Slides Video
Presentation thumbnail
Prevalence and predictors of residual shunt in patient undergoing patent foramen ovale closure
Doctor S. Ragonese (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Device-related thrombus after percutaneous intervention for Atrial Septal Defect (ASD) and Patent Foramen Ovale (PFO)
Mr L. Heusel (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Percutaneous closure of patent foramen ovale in refractory hypoxemia and platypnea-orthodeoxia syndrome 
Doctor G. Ndiaye (Strasbourg, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Patent foramen ovale closure

The Event

Event poster

ESC Congress 2025

30 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Percutaneous closure of patent foramen ovale in refractory hypoxemia and platypnea-orthodeoxia syndrome 
thumbnail
Congress Presentation
A rare case of Platypnea-Orthodeoxia after abdominal surgery
thumbnail
Congress Presentation
Incidence, determinants, and impact of in-hospital complications during percutaneous patent foramen ovale closure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources